Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
08:00am, Thursday, 20'th Jun 2024
Ms. Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director NORTH CHICAGO, Ill.
7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027
07:30am, Thursday, 20'th Jun 2024
While investing, the focus is on the top blue-chip stocks to buy that offer growth with stability. It is vital to comprehend the fundamentals that characterize these superior stocks.
3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition
06:00am, Thursday, 20'th Jun 2024
Building a portfolio today can be both easy and difficult. It's easy because every bit of data you need to make your choices is available 24/7 with a few taps on the screen.
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
12:45pm, Wednesday, 19'th Jun 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
Here's Why AbbVie (ABBV) is a Strong Momentum Stock
10:50am, Wednesday, 19'th Jun 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
09:46am, Wednesday, 19'th Jun 2024
AbbVie's (ABBV) Skyrizi is now approved for four indications across immune-mediated inflammatory diseases.
My Dividend Stock Portfolio: New May Dividend Record - 101 Holdings With 22 Buys
08:10am, Wednesday, 19'th Jun 2024
Investment activity remained high in April, focusing on BDCs aiming to increase dividend income by at least $100 each month. Main portfolio picks included Ares Capital, Hercules Capital, Goldman Sachs
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
04:19am, Wednesday, 19'th Jun 2024
Many dividend stocks have recently taken a back seat to growth stocks. However, dividend stocks offer several advantages to investors.
AbbVie says FDA approves Skyrizi for ulcerative colitis
06:59pm, Tuesday, 18'th Jun 2024
Drug maker AbbVie Inc. on Tuesday said the Food and Drug Administration had approved its drug Skyrizi for adults with moderate to severe forms of ulcerative colitis, broadening the company's arsenal o
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
06:51pm, Tuesday, 18'th Jun 2024
In the closing of the recent trading day, AbbVie (ABBV) stood at $171.36, denoting a +0.99% change from the preceding trading day.
Approval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance
AbbVie: 5 Reasons That Make A Buy Case
05:37pm, Tuesday, 18'th Jun 2024
AbbVie's weak stock price performance in the past quarter is in no way an indication of the progress it has made in recent months. Turnaround in revenue growth following Humira's patent expiration is
2 Dividend Stocks That Could Pay You for Life
08:30am, Sunday, 16'th Jun 2024
AbbVie's strength lies in its ability to innovate. Visa's success is tied to an ongoing long-term trend.
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer
04:08pm, Friday, 14'th Jun 2024
NORTH CHICAGO, Ill. , June 14, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) has been notified that Tutanota LLC (Tutanota) has commenced an unsolicited "mini-tender" offer, dated May 28, 2024, to purchase
Final Trades: Nvidia, Abbvie, ConocoPhillips and Vertex Pharma
01:29pm, Friday, 14'th Jun 2024
The Investment Committee share their top stocks to watch for the second half.
